Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio B Gonzalez

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 8, 2008
Unusual Occurrence of renal cell carcinoma (RCC) diagnosed in 2 young Hispanic patients with diffuse systemic sclerosis (dSSc)Michelle E Eisenberg, Prashanth R Sunkureddi, Bruce A Baethge, et al.
Plos One|October 18, 2016
Significance of Lipid-Derived Reactive Aldehyde-Specific Immune Complexes in Systemic Lupus ErythematosusGangduo Wang, Silvia S Pierangeli, Rohan Willis, et al.
Journal of Autoimmunity|February 25, 2019
Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndromeAsaf Shemer, Rohan Willis, Emilio B Gonzalez, et al.
Arthritis Care & Research|February 13, 2013
Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis?Xiaochun Liu, Maureen D Mayes, Claudia Pedroza, et al.
Frontiers in Immunology|April 28, 2022
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid SyndromeRohan Willis, Thomas C R McDonnell, Charis Pericleous, et al.
Plos One|November 9, 2013
Right bundle branch block: a predictor of mortality in early systemic sclerosisHilda T Draeger, Shervin Assassi, Roozbeh Sharif, et al.
Arthritis and Rheumatism|October 12, 2012
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosisXiaochun Liu, Maureen D Mayes, Filemon K Tan, et al.
Plos One|October 25, 2011
Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohortShervin Assassi, Astrud L Leyva, Maureen D Mayes, et al.
Arthritis and Rheumatism|February 1, 2011
HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisisBinh Nguyen, Maureen D Mayes, Frank C Arnett, et al.
Rheumatology International|June 6, 2022
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based reviewDaniel Gonzalez, Latika Gupta, Vijaya Murthy, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|January 8, 2008
Unusual Occurrence of renal cell carcinoma (RCC) diagnosed in 2 young Hispanic patients with diffuse systemic sclerosis (dSSc)Michelle E Eisenberg, Prashanth R Sunkureddi, Bruce A Baethge, et al.
Plos One|October 18, 2016
Significance of Lipid-Derived Reactive Aldehyde-Specific Immune Complexes in Systemic Lupus ErythematosusGangduo Wang, Silvia S Pierangeli, Rohan Willis, et al.
Journal of Autoimmunity|February 25, 2019
Oral administration of Domain-I of beta-2glycoprotein-I induces immunological tolerance in experimental murine antiphospholipid syndromeAsaf Shemer, Rohan Willis, Emilio B Gonzalez, et al.
Arthritis Care & Research|February 13, 2013
Does C-reactive protein predict the long-term progression of interstitial lung disease and survival in patients with early systemic sclerosis?Xiaochun Liu, Maureen D Mayes, Claudia Pedroza, et al.
Frontiers in Immunology|April 28, 2022
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid SyndromeRohan Willis, Thomas C R McDonnell, Charis Pericleous, et al.
Plos One|November 9, 2013
Right bundle branch block: a predictor of mortality in early systemic sclerosisHilda T Draeger, Shervin Assassi, Roozbeh Sharif, et al.
Arthritis and Rheumatism|October 12, 2012
Correlation of interferon-inducible chemokine plasma levels with disease severity in systemic sclerosisXiaochun Liu, Maureen D Mayes, Filemon K Tan, et al.
Plos One|October 25, 2011
Predictors of fatigue severity in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohortShervin Assassi, Astrud L Leyva, Maureen D Mayes, et al.
Arthritis and Rheumatism|February 1, 2011
HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisisBinh Nguyen, Maureen D Mayes, Frank C Arnett, et al.
Rheumatology International|June 6, 2022
Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based reviewDaniel Gonzalez, Latika Gupta, Vijaya Murthy, et al.
Pageof 3